Thomas Jefferson University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Thomas Jefferson University sits in the top decile of US sponsors by registered trial count (#118 of 15,742 sponsors by registered trial count).
Thomas Jefferson University: 292 sponsored US clinical trials, 54 recruiting.
Thomas Jefferson University sponsors 292 registered US clinical trials on ClinicalTrials.gov, 54 of them currently recruiting, and 182 completed. 46 of these trials are in Phase 3-4 (later-stage) and 73 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Malignant Solid Neoplasm, with 4 trials.
Top-decile sponsor footprint
Thomas Jefferson University ranks in the top decile of sponsors by registered trial count (#118 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
182 of 210 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
292 total, page 4 of 6
POCUS Analysis of the Gastric Emptying Time of Orange Juice With and Without Pulp
NCT04146233
Toward Zero Prescribed Opioids for Outpatient General Surgery
NCT05327777
Exercise Prescription for the Improvement of Quality of Life in Elderly Patients With Multiple Myeloma
NCT04100044
Patients With Heart Failure With Preserved Ejection Fraction Adherence to ASV Therapy (PEP ASV)
NCT04133350
Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor
NCT04122118
Trial of Simulation-based Mastery Learning to Communicate Diagnostic Uncertainty
NCT04021771
The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients
NCT03789968
Whipple Protein Study
NCT04306874
Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence
NCT04054557
Acceptance and Commitment Therapy vs. Supportive Psychotherapy With Cystic Fibrosis Patients
NCT04114227
Proactive Outreach and Shared Decision Making in Improving Lung Cancer Screening Rates in Primary Care Patients
NCT03929926
The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery
NCT03897621
Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences
NCT03955640
3 Local Anesthetics for Spinal Anesthesia in Primary Total Hip Arthroplasty
NCT03948386
Neuromotor Prosthetic to Treat Stroke-Related Paresis
NCT03913286
Ketamine for Refractory Chronic Migraine: a Pilot Study
NCT03896256
A Computer-Based System for Symptom Reporting in Patients With Cancer Undergoing Treatment
NCT03979846
Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer
NCT03944265
Needle-Knife Fistulotomy Vs. Standard Cannulation Trial
NCT06694038
Evaluation of Closed Incision Negative Pressure Dressing (PREVENA) to Prevent Lower Extremity Amputation Wound Complications
NCT03773575
Reducing Emergency Diabetes Care for Older African Americans
NCT03466866
Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis
NCT03685747
Comparative Analysis of Sutures for Fascial Closure in Spinal Surgery
NCT03533595
Coaching for Caregivers of Children With Spinal Cord Injury
NCT03898700
Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure
NCT03608696
Assessing Virologic Success and Metabolic Changes in Patients Switching From a TDF to TAF Containing Antiretroviral Therapy Regimen
NCT03646370
Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study
NCT03411252
Virtual Reality-enhanced Exercise and Education in Cardiac Rehabilitation
NCT03945201
Evaluation of Splinting in Tetraplegia
NCT04523636
Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound
NCT03245255
Treatment of Post-Operative Sinonasal Polyposis With Topical Furosemide
NCT03362515
Pharmacokinetics of Progesterone in Pregnancy
NCT03340701
Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix
NCT03251729
Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer
NCT03199274
Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement
NCT03243942
Enhancing Postpartum Discharge Instructions
NCT03592628
Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus
NCT03083782
Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study
NCT02967458
Diabetes Interprofessional Team to Enhance Adherence to Medical Care
NCT03393338
Evaluation of a Novel Technique to Investigate CAS Piezo Electric Sensors
NCT03041168
Apixaban Discontinuation Prior to Major Surgery
NCT02935751
Expedited Interval Tubal Scheduling
NCT02875483
Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth
NCT02913495
Gluten Ingestion Biomarkers in Patients w Gluten Sensitivity and Healthy Controls Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled Study
NCT02936297
Concept Mapping as a Scalable Method for Identifying Patient-Important Outcomes
NCT02792777
Effects and Mechanisms of Melatonin on Blood Pressure, Insulin Resistance, and Platelets
NCT03178396
Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson's Disease
NCT02443779
Physical Exam Indicated Cerclage in Twin Gestations
NCT02490384
Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation
NCT02440334
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension
NCT02489045
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 39 |
| Phase 2 | 34 |
| Phase 3 | 19 |
| Phase 4 | 27 |
What is open in the Thomas Jefferson University pipeline
54 recruiting of 292 indexed (18% open); 182 completed (62%).
Phase mix: 46 late (III/IV) vs 73 early (I/II) (early-phase heavy).
Top condition: Malignant Solid Neoplasm (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Thomas Jefferson University: open-pipeline peers nationwide
Peers matched on 292 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Thomas Jefferson University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 292 trials (± recruiting share)
- University of Michigan Rogel Cancer Center · 292 trials · 15% recruiting
- University of Missouri-Columbia · 291 trials · 19% recruiting
- Kaiser Permanente · 294 trials · 7% recruiting
- Eisai · 287 trials · 2% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Florida Atlantic University · 19% recruiting · 27 trials
- Institut de Recherches Internationales Servier · 19% recruiting · 27 trials
- Natera · 19% recruiting · 27 trials
- Nemours Children's Clinic · 19% recruiting · 108 trials
Related
What to do with this Thomas Jefferson University page
292 registered trials is a research-attention snapshot, not an endorsement of Thomas Jefferson University or any single study.
- 54 of Thomas Jefferson University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Malignant Solid Neoplasm is the condition Thomas Jefferson University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Malignant Solid Neoplasm trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Thomas Jefferson University pipeline card: 292 registered trials from official public datasets.Report a data error.